Judy M Hickman-Davis Selected Research

Infections

1/2021	Postexposure Liponucleotide Prophylaxis and Treatment Attenuates Acute Respiratory Distress Syndrome in Influenza-infected Mice.
1/2018	ATP catabolism by tissue nonspecific alkaline phosphatase contributes to development of ARDS in influenza-infected mice.
9/2013	Heterozygosity for the F508del mutation in the cystic fibrosis transmembrane conductance regulator anion channel attenuates influenza severity.
10/2007	Post-infection A77-1726 blocks pathophysiologic sequelae of respiratory syncytial virus infection.
8/2007	Respiratory syncytial virus induces insensitivity to beta-adrenergic agonists in mouse lung epithelium in vivo.
1/2007	Surfactant dysfunction in SP-A-/- and iNOS-/- mice with mycoplasma infection.
3/2006	Leflunomide prevents alveolar fluid clearance inhibition by respiratory syncytial virus.
3/2004	Role of surfactant protein-A in nitric oxide production and mycoplasma killing in congenic C57BL/6 mice.
1/2004	Nucleotide-mediated inhibition of alveolar fluid clearance in BALB/c mice after respiratory syncytial virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Judy M Hickman-Davis Research Topics

Disease

9	Infections 01/2021 - 01/2004
5	Hypoxia (Hypoxemia) 01/2021 - 03/2006
3	Human Influenza (Influenza) 01/2021 - 09/2013
3	Pulmonary Edema 01/2021 - 01/2018
3	Mycoplasma Infections 01/2007 - 03/2004
2	Pneumonia (Pneumonitis) 01/2021 - 10/2007
2	Respiratory Syncytial Virus Infections 03/2006 - 01/2004
1	Inflammation (Inflammations) 01/2021
1	Bronchiolitis 10/2007
1	Lung Injury 01/2007
1	Disease Progression 03/2006
1	Hyperoxia 04/2003
1	Lung Diseases (Lung Disease) 04/2003

Drug/Important Bio-Agent (IBA)

3	NucleotidesIBA 01/2018 - 01/2004
3	Adenosine Triphosphate (ATP)IBA 01/2018 - 01/2004
2	Surface-Active Agents (Surfactants)IBA 01/2021 - 01/2007
2	EnzymesIBA 01/2018 - 01/2004
2	Leflunomide (Arava)FDA LinkGeneric 10/2007 - 03/2006
2	pyrimidineIBA 10/2007 - 03/2006
2	Uridine Triphosphate (UTP)IBA 03/2006 - 01/2004
2	Amiloride (Midamor)FDA LinkGeneric 02/2006 - 01/2004
2	Oxygen (Dioxygen)IBA 02/2006 - 04/2003
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021
1	Cytidine Diphosphate (CDP)IBA 01/2021
1	Cytidine Diphosphate Choline (Citicoline)IBA 01/2021
1	Cytidine Diphosphate Diglycerides (CDP-Diacylglycerol)IBA 01/2021
1	DiglyceridesIBA 01/2021
1	3-nitrotyrosineIBA 01/2021
1	LipidsIBA 01/2021
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2021
1	Aligeron (AS 2)IBA 01/2018
1	5'-Nucleotidase (5' Nucleotidase)IBA 01/2018
1	Alkaline PhosphataseIBA 01/2018
1	Adenosine (Adenocard)FDA LinkGeneric 01/2018
1	AnionsIBA 09/2013
1	Liposomes (Liposome)IBA 09/2013
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 09/2013
1	Interleukin-6 (Interleukin 6)IBA 09/2013
1	Clodronic Acid (Clodronate)IBA 09/2013
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 10/2007
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 08/2007
1	ColforsinIBA 08/2007
1	8-Bromo Cyclic Adenosine Monophosphate (8 Bromo Cyclic Adenosine Monophosphate)IBA 08/2007
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 03/2006
1	Purinergic Receptors (Receptors, Purine)IBA 03/2006
1	purineIBA 03/2006
1	NitrogenIBA 02/2006
1	SodiumIBA 02/2006
1	NitratesIBA 03/2004
1	NitritesIBA 03/2004
1	Pulmonary Surfactant-Associated Protein A (Surfactant Protein A)IBA 03/2004
1	Suramin (Suramin Sodium)IBA 01/2004
1	XAMR 0721IBA 01/2004
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2003
1	Free RadicalsIBA 04/2003